Mount Yale Investment Advisors, LLC - AIMMUNE THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 147 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

Links
Filings
External links
Quarter-by-quarter ownership
Mount Yale Investment Advisors, LLC ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$27,000
+68.8%
834
+42.3%
0.01%
+66.7%
Q2 2018$16,000–586–0.00%–
 Download
Other shareholders

There were no reported owners of AIMMUNE THERAPEUTICS INC in Q3 2018.

NameSharesValueWeighting ↓
View complete list of AIMMUNE THERAPEUTICS INC shareholders